Earum Pharmaceuticals has informed that the Board of Directors in their meeting held today,19th April, 2023 at the Registered Office of the Company which commenced at 3:00 pm and concluded at 3:30pm has considered and adopted Letter of Offer and Abridged Letter of Offer to be filed with BSE and any other authority, as applicable and will be dispatched to the Eligible Equity Shareholders of the Company as on the Record Date - 10th April, 2023; Decided the schedule of the Rights Issue: Issue opening day and date Tuesday, 2nd May, 2023, Last date for On Market Renunciation of the Rights Entitlements - Friday, 26th May, 2023, and Issue closing will be on Wednesday, 31st May, 2023.
The above information is a part of company’s filings submitted to BSE.
